Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-(4-chlorophenyl)-6,7-dimethoxyquinazolin-4(3H)-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

228118-56-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 228118-56-7 Structure
  • Basic information

    1. Product Name: 2-(4-chlorophenyl)-6,7-dimethoxyquinazolin-4(3H)-one
    2. Synonyms: 2-(4-chlorophenyl)-6,7-dimethoxyquinazolin-4(3H)-one
    3. CAS NO:228118-56-7
    4. Molecular Formula:
    5. Molecular Weight: 316.744
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 228118-56-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-(4-chlorophenyl)-6,7-dimethoxyquinazolin-4(3H)-one(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-(4-chlorophenyl)-6,7-dimethoxyquinazolin-4(3H)-one(228118-56-7)
    11. EPA Substance Registry System: 2-(4-chlorophenyl)-6,7-dimethoxyquinazolin-4(3H)-one(228118-56-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 228118-56-7(Hazardous Substances Data)

228118-56-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 228118-56-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,8,1,1 and 8 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 228118-56:
(8*2)+(7*2)+(6*8)+(5*1)+(4*1)+(3*8)+(2*5)+(1*6)=127
127 % 10 = 7
So 228118-56-7 is a valid CAS Registry Number.

228118-56-7Relevant articles and documents

Iron(III) Chloride-Catalyzed Decarboxylative-Deaminative Functionalization of Phenylglycine: A Tandem Synthesis of Quinazolinones and Benzimidazoles

Kumar, Manoranjan,Richa,Sharma, Sushila,Bhatt, Vinod,Kumar, Neeraj

supporting information, p. 2862 - 2868 (2015/09/28)

The first iron(III) chloride-catalyzed decarboxylative-deaminative functionalization of phenylglycine with o-substituted nitroarenes was achieved for the synthesis of 4(3H)-quinazolinones and benzimidazoles. The reaction of 2-nitrobenzonitrile/2-nitro-N,N-diphenylamine with phenylglycine at 120 C in the presence of potassium carbonate as a base in toluene generated the products in 45-87% yields. Various functional groups like nitro, fluoride, chloride and trifluoromethyl were well tolerated under the present reaction conditions. In this tandem approach, involvement of transfer hydrogenation of the nitro functionality with in situ generated ammonia, imination, nitrile hydration to amide and oxidative cyclization sequences have been established. The process avoids the use of an external hydrogen source, costly catalysts as well as the isolation of amine and amide intermediates.

6,7-dimethoxyquinazolines as potential cytotoxic agents: Synthesis and in vitro activity

Yadav, Mange Ram,Chauhan, Bishram Singh,Naik, Prashant,Gandhi, Hardik,Giridhar, Rajani

, p. 190 - 205 (2015/04/14)

It has been reported that 6,7-dimethoxyquinazoline derivatives have cytotoxic potential independent of their a1-adrenoceptor blocking potential. Bioisosteres of 2-arylquinazolines are considered to have anti-tumor properties. In the present study, we have synthesized the 2-aryl and 2-arylmethyl derivatives of quinazolin-4(3H)-one while retaining the 6,7-dimethoxy substituents. Derivatives with n-butyl group attached to position-3 of quinazolinone nucleus were synthesized with the aim of increasing their lipophilicity. The potential of these synthesized compounds was evaluated against NCI (National Cancer Institute) 60 cell panel using the NCI disease oriented antitumor screen protocol. Based on the results of this screening we generalized that compounds having aryl groups directly attached to the quinazoline ring are less active than those which have one atom linker in between the two ring systems. Substitution of a lipophilic group like nbutyl decreases cytotoxic activity among the compounds and 4-aminoquinazolines showed better activity than 4-quinazolinones. Lipophilic groups in the aromatic ring yielded more active compounds as cytotoxic agents. Among the selected compounds, 4h and 13b were found to be potential lead compounds which could be further optimized as potential anti-neoplastic agents.

SUBSTITUTED 4-(SELENOPHEN-2(OR-3)-YLAMINO)PYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF

-

, (2013/10/22)

Selenophene compounds of formula (I) are described herein. In the compounds of Formula (I), ring A is a 6-membered aromatic fused ring, optionally containing one, two or three nitrogen atoms; a 5-membered heteroaromatic fused ring; or a mono- or bicyclic

Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments

-

, (2008/06/13)

Compounds of the formula I in which R1, R2, R3and Ar have the meanings indicated in the claims, are suitable for the production of pharmaceuticals, for example for the prophylaxis and therapy of cardiovascular diseases suc

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 228118-56-7